Mersana Therapeutics, Inc.
Status: Publicly traded
Direct answer
Mersana Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MRSN.
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering novel antibody-drug conjugates (ADCs) for cancer patients with pressing unmet medical needs. Their flagship product candidate, XMT-1592, a Dolasynthen ADC engineered to target NaPi2b-expressing tumor cells, is presently undergoing Phase I clinical evaluation for the treatment of ovarian cancer and NSCLC adenocarcinoma....
Can you invest in Mersana Therapeutics, Inc.?
Yes. Mersana Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MRSN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Mersana Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.